EWP
INSP icon

Elevation Wealth Partners’s Inspire Medical Systems INSP Stock Holding History

Elevation Wealth Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.16K Hold
60
– – ﹤0.01% 1135
2026
Q2 		$2.68K Buy
+60
New +$2.85K ﹤0.01% 1153

Other funds holding INSP

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Elevation Wealth Partners's INSP Position: Q3 2026 in Review

Elevation Wealth Partners held its Inspire Medical Systems (INSP) position steady in Q3 2026 at 60 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Elevation Wealth Partners first reported a position in INSP in Q2 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Elevation Wealth Partners held 60 shares of Inspire Medical Systems worth $4.16K as of Q3 2026.
  • Elevation Wealth Partners left its Inspire Medical Systems share count unchanged in Q3 2026.
  • Inspire Medical Systems made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1135 holding.
  • Elevation Wealth Partners first reported a position in Inspire Medical Systems in Q2 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.